Americ N Astos Medicament Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -21.51%
- Profit Growth -79.58%
- Ebitda -4.03%
- Net Worth 14.22%
- Total Assets 55.31%
About Americ N Astos Medicament
Americ N Astos Medicament Private Limited (ANAMPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2008 and has a history of 16 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amitabh Mishra and Avinash Mishra serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2008PTC180010
-
Company No.
180010
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 2008
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Americ N Astos Medicament?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amitabh Mishra
|
Director | 25-Jun-2008 | Current |
|
Avinash Mishra
|
Director | 25-Jun-2008 | Current |
Financial Performance of Americ N Astos Medicament.
Americ N Astos Medicament Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 21.51% decrease. The company also saw a substantial fall in profitability, with a 79.58% decrease in profit. The company's net worth Soared by an impressive increase of 14.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Americ N Astos Medicament?
In 2018, Americ N Astos Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Americ N Astos Medicament?
Unlock and access historical data on people associated with Americ N Astos Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Americ N Astos Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Americ N Astos Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.